I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent ...

The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

President Donald Trump downplays the influence of Laura Loomer, a right-wing provocateur, in his administration’s ...

Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the ...

The motivation is solely what we think is in the public interest— the accurate judgment of benefits and risks,” Prasad wrote.

Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

Risky Research Review Act aims to create a more cohesive system with greater oversight for gain-of-function research.